Seres Therapeutics competitive analysis

Explore patent oppositions filed by Seres Therapeutics against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 17, 2026
Patent NumberTitleApplicantOpposition Date
Composition For Inducing Proliferation Or Accumulation Of Regulatory T CellsTHE UNIVERSITY OF TOKYOApr 25, 2017

Latest PTAB cases involving Seres Therapeutics

Discover the latest PTAB cases involving Seres Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Seres Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SERES THERAPEUTICS1 - - -
THE UNIVERSITY OF TOKYO - 28 - 1